Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2015 Aug;5(4):360–371. doi: 10.1007/s13346-015-0228-0

Fig. 1. Preservation of total protein and active hemagglutinin content during vaccine processing as estimated by protein (BCA) and SRID assays, respectively.

Fig. 1

a) A/Victoria/210/09 vaccine; b) B/Brisbane/60/08 vaccine, HA: hemagglutinin. Gray and blue columns represent original and concentrated monobulks, respectively. (*** p < 0.0001.)